Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — November 2020

Planlagt Fastgjort Låst Flyttet Genmab
1.4k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • P Offline
    P Offline
    Plimsoller
    wrote on sidst redigeret af
    #241

    And equally good for the wallet 😉

    1 Reply Last reply
    0
    • E Offline
      E Offline
      E_L
      wrote on sidst redigeret af
      #242

      larger trendline resistance really only above 2900

      1 Reply Last reply
      0
      • SolsenS Offline
        SolsenS Offline
        Solsen
        wrote on sidst redigeret af
        #243

        I think if Tapezza, Kesimpta, Darzalex still performing excellent. Amivantamab and TF is on its way to approval we reach a milestone with 3.000 DKK in 2021.

        1 Reply Last reply
        0
        • S Offline
          S Offline
          Sukkeralf
          wrote on sidst redigeret af
          #244

          I agree.................and if a BsAb like PD-L1/4-1BB with the magnitude of 10 billion dollars or higher starts to show off then its hard to guess were we are going

          1 Reply Last reply
          0
          • S Offline
            S Offline
            Sukkeralf
            wrote on sidst redigeret af
            #245

            early days still but valuation comes also early these days

            1 Reply Last reply
            0
            • StockBullS Offline
              StockBullS Offline
              StockBull
              wrote on sidst redigeret af
              #246

              https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/88181_genmab_rykker.JPG Tror vi skal op og ligge og swinge mellem 2350 til 2650 kommende måneder. Har indikeret en mindre stejl kurve. Har selvfølgelig ikke ikke noget imod Genmab forbliver i den stejle kurve

              1 Reply Last reply
              0
              • Helge_LarsenPI-redaktørH Offline
                Helge_LarsenPI-redaktørH Offline
                Helge_LarsenPI-redaktør
                wrote on sidst redigeret af
                #247

                Genmab/CEO: Darzalex suppleres af flere nye trækheste i 2021
                https://www.proinvestor.com/investornyt/669340/genmab-ceo-darzalex-suppleres-af-flere-nye-traekheste-i-2021

                1 Reply Last reply
                0
                • SolsenS Offline
                  SolsenS Offline
                  Solsen
                  wrote on sidst redigeret af
                  #248

                  Du var sekundet hurtigere Helge. Bid mærke i, at JW forventer pæne indtægter fra Amivantamab i 2021.

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #249

                    did he not also compare Epcoritamab
                    to Dara in an interview or am i wrong now?

                    1 Reply Last reply
                    0
                    • SolsenS Offline
                      SolsenS Offline
                      Solsen
                      wrote on sidst redigeret af
                      #250

                      Yes we forgot Epco 😉 Judith did tell that they will persude all b-cell indications.

                      1 Reply Last reply
                      0
                      • SolsenS Offline
                        SolsenS Offline
                        Solsen
                        wrote on sidst redigeret af
                        #251

                        As I recall 🙂

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #252

                          and dont forget Dara , many abstracts at ASH and

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #253

                            Janssen Seeks Expanded Use of DARZALEX®▼ (daratumumab) Subcutaneous Formulation for the Treatment of Patients with Light Chain (AL) Amyloidosis https://www.businesswire.com/news/home/20201105005525/en/Janssen-Seeks-Expanded-Use-of-DARZALEX®▼-daratumumab-Subcutaneous-Formulation-for-the-Treatment-of-Patients-with-Light-Chain-AL-Amyloidosis

                            1 Reply Last reply
                            0
                            • SolsenS Offline
                              SolsenS Offline
                              Solsen
                              wrote on sidst redigeret af
                              #254

                              Stockbull på dit chart er tallene i højre side ikke synlige. De ville være interessante - tak 🙂

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #255

                                and Genmab also announcing the EMA s
                                ubmission https://ir.genmab.com/news-releases/news-release-details/genmab-announces-janssen-has-submitted-type-ii-variation

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #256

                                  triggers a USD 5 million milestone payment to Genmab.

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #257

                                    nobody even bothers mentioning that anymore lol

                                    1 Reply Last reply
                                    0
                                    • Helge_LarsenPI-redaktørH Offline
                                      Helge_LarsenPI-redaktørH Offline
                                      Helge_LarsenPI-redaktør
                                      wrote on sidst redigeret af
                                      #258

                                      Genmab-partner søger om tillægsgodkendelse for Darzalex i Europa - NY
                                      https://www.proinvestor.com/investornyt/669343/genmab-partner-soger-om-tillaegsgodkendelse-for-darzalex-i-europa-ny

                                      1 Reply Last reply
                                      0
                                      • Helge_LarsenPI-redaktørH Offline
                                        Helge_LarsenPI-redaktørH Offline
                                        Helge_LarsenPI-redaktør
                                        wrote on sidst redigeret af
                                        #259

                                        Jeg minder lige om denne analyse:
                                        https://www.proinvestor.com/boards/86703/Teknisk-analyse-af-Genmab

                                        1 Reply Last reply
                                        0
                                        • BulderB Offline
                                          BulderB Offline
                                          Bulder
                                          wrote on sidst redigeret af
                                          #260

                                          Har vi hørt noget om størrelsen af markedet for den særlige type af nsclc, som ami retter sig imod?

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger